Chemomab Therapeutics Ltd expected to post a loss of 1 cent a share - Earnings Preview

Chemomab Therapeutics

19/08/2024 13:14

* Chemomab Therapeutics Ltd  CMMB.OQ   CMMB.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 21 for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Chemomab Therapeutics
Ltd is
for a loss of 1 cent per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for Chemomab
Therapeutics Ltd is $9.00​, above​ its last closing price
of $1.11. ​​​

This summary was machine generated August 19 at 12:14 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)